Research location
Choroszcz
Poland
Advertisement
Research activity in Choroszcz
PolandCureCurrent currently publishes aggregate city-level research activity for this location: 17 trials and 19 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Choroszcz
17 linked trials · page 1 of 1Efficacy, Safety and Pharmacokinetics Study of CPL500036 (PDE10A Inhibitor) in Patients With SchizophreniaNCT05278156 · 2021-05-19 · 1 site observation
COMPLETED
Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant DepressionNCT03965858 · 2019-02-25 · 1 site observation
COMPLETED
Study to Evaluate Efficacy and Safety of Roluperidone (MIN-101) in Adult Patients With Negative Symptoms of SchizophreniaNCT03397134 · 2017-12-15 · 1 site observation
COMPLETED
Brexpiprazole in Patients With SchizophreniaNCT01810783 · 2013-07-01 · 2 site observations
COMPLETED
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant TherapyNCT01437657 · 2011-10-01 · 1 site observation
COMPLETED
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With SchizophreniaNCT01397786 · 2011-09-01 · 1 site observation
COMPLETED
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute SchizophreniaNCT01396421 · 2011-07-01 · 1 site observation
COMPLETED
A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25306)NCT01235585 · 2010-12-01 · 1 site observation
COMPLETED
A Study of RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25309)NCT01192906 · 2010-12-01 · 1 site observation
COMPLETED
Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)NCT01111565 · 2010-10-04 · 2 site observations
TERMINATED
An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Participants With SchizophreniaNCT01129882 · 2010-06-24 · 1 site observation
COMPLETED
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With SchizophreniaNCT00731549 · 2008-12-01 · 1 site observation
COMPLETED
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With SchizophreniaNCT00706654 · 2008-09-01 · 1 site observation
COMPLETED
Efficacy of Bifeprunox in Patients With SchizophreniaNCT00704509 · 2008-06-01 · 1 site observation
TERMINATED
Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's TypeNCT00160147 · 2005-12-01 · 1 site observation
TERMINATED
A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective DisorderNCT00216476 · 2004-10-01 · 1 site observation
COMPLETED
Long-Term Safety Of DVS-233 SR In Patients With Major Depressive DisorderNCT01309542 · 2003-08-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.